Published Works

Our Scientific staff have published many papers, please peruse our list to see all of our works.

In addition to the publications below, Dr Simon Elliott has also published other works; please contact us for more information.

2016

  1. McLaughlin G, Morris N, Kavanagh PV, Power JD, O'Brien J, Talbot B, Elliott SP, Wallach J, Hoang K, Morris H, Brandt SD (2016). Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its meta- and para-substituted isomers. Drug Test Anal. 8(1); 99-110.
  2. Gerostamoulos D, Elliott S, Walls HC, Peters FT, Lynch M, Drummer OH (2016), To measure or not to measure? That Is the NPS question. J. Anal. Toxicol. 40(4); 318-320.
  3. Elliott SP, Brandt SD, Smith C (2016), The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis. Drug Test Anal. 8(8); 875-879.
  4. Brandt SD, Kavanagh PV, Westphal F, Elliott SP, Wallach J, Colestock T, Burrow TE, Chapman SJ, Stratford A, Nichols DE, Halberstadt AL (2016). Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ). Drug Test Anal. Jun 6. doi: 10.1002/dta.1985. [Epub ahead of print]
  5. Elliott SP, Burke T, Smith C (2016). Determining the toxicological significance of pregabalin in fatalities. J. Forensic Sci. (in press).
  6. Wallach J, Colestock T, Cicali B, Elliott SP, Kavanagh PV, Adejare A, Dempster NM, Brandt SD (2016). Syntheses and analytical characterizations of N-alkyl-arylcyclohexylamines. Drug Test Anal. 8(8); 801-815.
  7. Elliott, S. (2016). “Mephedrone and New Psychoactive Substances” in Forensic Toxicology: Drug Use and Misuse (Davies, Johnston and Holt, Editors), Pages 94-126, Royal Society of Chemistry, UK.

2015

  1. Elliott, S.P., Brandt, S.D., Wallach, J., Morris, H. and Kavanagh, P.V (2015). First Reported Fatalities Associated with the 'Research Chemical' 2-Methoxydiphenidine. J Anal Toxicol. 39(4); 287-293.
  2. Nichols, D.E., Sassano, M.F., Halberstadt, A.L., Klein, L.M., Brandt, S.D., Elliott, S.P. and Fiedler, W.J (2015). N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues. ACS Chem Neurosci. 6(7); 1165-1175.
  3. Corkery JM, Loi B, Claridge H, Goodair C, Corazza O, Elliott S, Schifano F (2015). Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use. Neurosci Biobehav Rev. 53; 52-78.
  4. Brandt SD, Elliott SP, Kavanagh PV, Dempster NM, Meyer MR, Maurer HH, Nichols DE (2015). Analytical characterization of bioactive N-benzyl-substituted phenethylamines and 5-methoxytryptamines. Rapid Commun Mass Spectrom. 29(7); 573-584.
  5. Elliott, S. (2015). “Forensic Toxicology” in Mason’s Forensic Medicine for Lawyers 6th Edition (Whitwell, Thorne, Kolar and Harvey, Editors), Pages 287-316, Bloomsbury Professional, UK.
  6. Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Hoang K, Wallach J, Halberstadt AL (2015). Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Drug Test Anal. Oct 12. doi: 10.1002/dta.1884. [Epub ahead of print]

2014

  1. Soh, Y.N. and Elliott, S (2014). An investigation of the stability of emerging new psychoactive substances. Drug Test Anal. 6(7-8); 696-704.
  2. Elliott, S. and Evans, J. (2014) A 3-year review of new psychoactive substances in casework. Forensic Sci Int. 243; 55-60.
  3. Wallach, J., Kavanagh, P.V., McLaughlin, G., Morris, N., Power, J.D., Elliott, S.P., Mercier, M.S., Lodge, D., Morris, H., Dempster, N.M. and Brandt, S.D (2014). Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers. Drug Test Anal. 7(5); 358-67.
  4. Brandt SD, Baumann MH, Partilla JS, Kavanagh PV, Power JD, Talbot B, Twamley B, Mahony O, O'Brien J, Elliott SP, Archer RP, Patrick J, Singh K, Dempster NM, Cosbey SH (2014). Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni'). Drug Test Anal. 6(7-8); 684-695.
  5. Cosbey S, Kirk S, McNaul M, Peters L, Prentice B, Quinn A, Elliott SP, Brandt SD, Archer RP (2014). Multiple fatalities involving a new designer drug: para-methyl-4-methylaminorex. J Anal Toxicol. 38(6); 383-384.

2013

  1. Corkery, J.M., Elliott, S., Schifano, F., Corazza, O. and Ghodse, A.H (2013). MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update. Hum Psychopharmacol. 28(4); 345-355.
  2. Elliott, S.P., Brandt, S.D., Freeman, S. and Archer, R.P (2013). AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis. Drug Test Anal. 5(3); 196-202.
  3. Taylor, K. and Elliott, S (2013). An unusual case of risperidone instability in a fatality presenting an analytical and interpretative challenge. Drug Test Anal. 5(9-10); 748-752.
  4. Parkin MC, Longmoore AM, Turfus SC, Braithwaite RA, Cowan DA, Elliott S, Kicman AT (2013). Detection of ketamine and its metabolites in human hair using an integrated nanoflow liquid chromatography column and electrospray emitter fritted with a single porous 10 μm bead. J Chromatogr A.1277; 1-6.
  5. Elliott, S (2013). Drug confirmation: strategy and methods. Forensic Drug Analysis. Oct; 60-70. Doi: 10.4155/ebo.13.51.

2012

  1. Corkery, J.M., Elliott, S., Schifano, F., Corazza, O. and Ghodse, A.H (2012). 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review. Prog Neuropsychopharmacol Biol Psychiatry. 39(2); 253-258.
  2. Corkery JM, Durkin E, Elliott S, Schifano F, Ghodse AH (2012). The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): a brief review. Prog Neuropsychopharmacol Biol Psychiatry. 39(2):259-262

2011

  1. Elliott, S. (2011). Cat and mouse: the analytical toxicology of designer drugs. Bioanalysis. 3 (3); 249-251.
  2. Elliott, S. (2011). Current awareness of piperazines: pharmacology and toxicology. Drug Test Anal. 3(7-8); 430-438

2010

  1. Elliott, S., Smith, C. and Cassidy, D. (2010). The post-mortem relationship between beta-hydroxybutyrate (BHB), acetone and ethanol in ketoacidosis. Forensic Sci. Int. (1-3); 53-57. Corrigendum published (2011) vol 206; 217.

2009

  1. Kintz, P., Evans, J., Villain., M., and Cirimele, V. (2009). Smoking Cessation with Varenicline: A Suicidal Fatality. J. Anal. Toxicol., 33, (2); 118-120.
  2. Kintz, P., Evans, J., Villain., M., Chatterton., C. and Cirimele, V. (2009). Hair Analysis to Demonstrate Administration of Sildenafil to a Woman in a Case of Drug Facilitated Assault. J. Anal. Toxicol., 33,(8) 553-556.
  3. Elliott, S., Woolacott, H. and Braithwaite, R.A. (2009). The prevalence of drugs and alcohol found in road traffic fatalities: A comparative study of victims. Science and Justice., 49; 19-23.
  4. Taylor, K and Elliott, S. (2009). A validated hybrid quadrupole linear ion-trap LC-MS method for the analysis of morphine and morphine glucuronides applied to opiate deaths. Forensic Sci. Int. 187 (1-3); 34-41.
  5. Rowell, F., Hudson, K. and Seviour, J. (2009). Detection of drugs and their metabolites in dusted latent fingermarks by mass spectrometry. Analyst. DOI:10.1039/b813957c.
  6. Turfus, S., Parkin, M., Cowan D., Halket, J., Smith, N., Braithwaite. R., Elliott, S., Steventon, G., and Kicman, A. (2009) Use of human microsomes and deuterated substrates: An alternative approach for the identification of novel metabolites of ketamine by mass spectrometry, Drug Metab Dispo, 37 (8); 1769-1778.

2008

  1. Elliott, S. and Smith, C. (2008). Investigation of the first deaths in the UK involving the piperazinesBZP and 3-TFMPP. J. Anal. Toxicol. , 32 (2) ; 172-177
  2. Elliott, S. (2008). “Forensic Toxicology” in Mason’s Forensic Medicine for Lawyers 5th Edition (Cowan and Hunt, Editors), Pages 415-427, Tottel Publishing, Haywards Heath, UK.
  3. Parkin, M., Turfus, S., Smith, N.W., Halket, J.M., Braithwaite, R.A., Elliott, S.P., Osselton, M.D., Cowan, D.A. and Kicman, A.T. (2008). Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography-tandem mass spectrometry. J. Chromatogr. B. , 876; 137-142

2007

  1. Kintz, P., Evans, J., Villain, M., Salquebre, G. and Cirimele, V. (2007). Hair analysis for diphenhydramine after surreptitious administration to a child. Forensic Sci. Int. 173, (2); 171-174
  2. Kintz, P., Evans, J., Villain, M., Salquebre, G. Pujol, M., Salquebre, G. and Cirimele, V. (2007). A case of abuse in which children were forced to take tablets containing scopolamine: segmental analysis of hair for scopolamine by ultra performance liquid chromatography-tandem mass spectrometry. Forensic Toxicology, 25, (1); 49-52